![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 9/48 | |
A61K 31/496 | |||
A61K 31/495 | |||
A61K 31/4704 | |||
A61K 47/12 | |||
A61K 9/14 | |||
A61K 9/20 | |||
A61K 31/4965 | |||
A61K 9/28 |
(11) | Patento numeris | 2800558 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13733789.5 |
Europos patento paraiškos padavimo data | 2013-01-04 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-11-12 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-11 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/KR2013/000057 |
Data | 2013-01-04 |
(87) | Numeris | WO 2013/103262 |
Data | 2013-07-11 |
(30) | Numeris | Data | Šalis |
20120001954 | 2012-01-06 | KR |
(72) |
KWON, Taek Kwan, KR
KIM, Dong Ho, KR
KIM, Kyeong Soo, KR
KIM, Yong Il, KR
PARK, Jae Hyun, KR
WOO, Jong Soo, KR
|
(73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
(54) | STABLE PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
STABLE PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION COMPRISING LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |